Side-by-Side Comparison · 2026

Neuromedin S vs Xenopsin

Neuromedin S vs Xenopsin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Neuromedin S
Neuropeptide

Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. However, NMS has a markedly different expression pattern: while NMU is broadly exp...

Calculate Neuromedin S dose →
Xenopsin
Neuropeptide

Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates neurotensin receptors....

Calculate Xenopsin dose →
Key Parameters
Parameter Neuromedin S Xenopsin
Category Neuropeptide Neuropeptide
Research Research Preclinical
Half-Life Short (minutes, estimated) Short
Typical Dose 1-10 nmol (central, animal) N/A (research)
Frequency Variable N/A
Route Intracerebroventricular, Subcutaneous IV / ICV (research)
FDA Status Not approved Not approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between Neuromedin S and Xenopsin?
Neuromedin S: Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. Ho... Xenopsin: Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates n...
Which has a longer half-life, Neuromedin S or Xenopsin?
Neuromedin S half-life: Short (minutes, estimated). Xenopsin half-life: Short.
Can you stack Neuromedin S and Xenopsin?
Neuromedin S and Xenopsin are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.